Showing all 5 results
Diphenylhydantoin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dissolution-Optimized Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive sodium salt.
Active Ingredient Strength Primary Clinical Function Diphenylhydantoin (Phenytoin) Sodium USP/Ph.Eur. 100 mg The Global Epilepsy Standard: The definitive therapeutic unit utilized globally for the chronic, daily maintenance and suppression of tonic-clonic and psychomotor seizures. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Povidone / Magnesium Stearate Diluent / Binder / Superdisintegrant / Glidant / Lubricant (Engineered specifically utilizing Strict Particle-Size Distribution (PSD) Control. Because the drug is highly insoluble, the API is micro-milled to an exact, mathematically defined micron size to guarantee a highly predictable, extended dissolution profile in the gut, preventing toxic “dose dumping”) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict chronic neurology dispensing regimens and therapeutic drug monitoring protocols).
Gabapentin Capsules
FreeGabapentin capsules (commonly 100 mg, 300 mg, and 400 mg) contain the active pharmaceutical ingredient gabapentin USP, along with a variety of inactive excipients that aid in the drug’s delivery and stability.
Gabapentine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the heavily compressed active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Gabapentin USP/Ph.Eur. 600 mg Global Neuropathy Standard: The definitive high-dose unit utilized for the aggressive, long-term maintenance of severe diabetic peripheral neuropathy and postherpetic neuralgia. Gabapentin USP/Ph.Eur. 800 mg Max-Dose Seizure & Refractory Pain Standard: Massive therapeutic payload utilized for high-dose titration (up to 3600 mg/day) in refractory partial-onset seizures and extreme nerve pain. Excipients Copovidone / Crospovidone / Microcrystalline Cellulose / Magnesium Stearate / Premium Polymeric Film High-Shear Binder / Superdisintegrant / Diluent / Slipper-Coating (Engineered specifically utilizing advanced wet-granulation to compress the massive, fluffy 800mg API into a dense, smooth, swallowable tablet, preventing the pill from becoming a dangerous choking hazard for elderly patients) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for chronic, high-volume daily dispensing regimens).
Lamotrigine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Rapid-Dispersible (DT) Tablet, packed exclusively in highly secure Alu-PVC or Alu-Alu blister strips, frequently customized into highly regulated Titration Starter Kits.
Active Ingredient Strength Primary Clinical Function Lamotrigine USP/Ph.Eur. 25 mg (Starter Kit) The SJS-Prevention Standard: Mandatory base unit for the strict, slow titration schedule required to prevent fatal cutaneous reactions. Often formulated as a Dispersible Tablet (DT) for pediatric epilepsy. Lamotrigine USP/Ph.Eur. 50 mg / 100 mg / 200 mg Global Maintenance Standard: High-efficacy adult maintenance doses for lifelong seizure control and bipolar stabilization. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Sucralose & Flavoring (If DT) / Magnesium Stearate Diluent / Superdisintegrant / Binder / Sweetener (Engineered specifically to either swallow intact or disperse rapidly in a teaspoon of water for children or elderly psychiatric patients suffering from dysphagia) *Pack Sizes: 10×10 Blisters, Bottles of 100, or Dedicated 28-Day Titration Calendar Packs (Optimized specifically to eliminate caregiver dosing errors during the critical initiation phase).
